Fortrea Holdings FTRE
NASDAQ FTRE
$18.24 -0.38 (-2.04%)
As of: Sep 4, 2026 · 12:49 PM EDT

Fortrea Holdings (FTRE) Change in Account Payables (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Change in Account Payables came in at -$16.7 million in Q2 2026, up 9.24% YoY from -$15.3 million in Q2 2025, and down 140.44% on a QoQ basis from $41.3 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Change in Account Payables (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Change in Account Payables data on file, last reported at -$16.7 million in Q2 2026.

  • Quarterly Change in Account Payables rose 9.24% year-over-year to -$16.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$38.5 million (up 26.81% YoY) and the FY2025 annual result came in at -$109.9 million, down 1626.39% from the prior year.
  • Change in Account Payables eased to -$16.7 million in Q2 2026, from $41.3 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $41.3 million in Q1 2026 to a low of -$42.9 million in Q3 2025.
  • A 5-year average of -$1.2 million and a median of $400000.0 in 2022 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2024 — Change in Account Payables soared 2880.0% — and 2025, when it sank 3055.56%.
  • Tracing FTRE's Change in Account Payables over 5 years: stood at $1.3 million in 2022, then soared by 623.08% to $9.4 million in 2023, then slumped by 85.11% to $1.4 million in 2024, then plunged by 1542.86% to -$20.2 million in 2025, then climbed by 17.33% to -$16.7 million in 2026.
  • The last three Change in Account Payables figures came in at -$16.7 million (Q2 2026), $41.3 million (Q1 2026), and -$20.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn -
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 5.03 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.52 Bn 27.68 Bn - -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn -16.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.70 Mn
Mar 31, 2026 41.30 Mn
Dec 31, 2025 -20.20 Mn
Sep 30, 2025 -42.90 Mn
Jun 30, 2025 -18.40 Mn
Mar 31, 2025 -28.40 Mn
Dec 31, 2024 1.40 Mn
Sep 30, 2024 -7.20 Mn
Jun 30, 2024 13.90 Mn
Mar 31, 2024 -900,000.00
Dec 31, 2023 9.40 Mn
Sep 30, 2023 26.00 Mn
Jun 30, 2023 -500,000.00
Mar 31, 2023 20.40 Mn
Dec 31, 2022 1.30 Mn
Sep 30, 2022 3.00 Mn